Stay updated on UNCOVER-2: Guselkumab Clinical Trial

Sign up to get notified when there's something new on the UNCOVER-2: Guselkumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the UNCOVER-2: Guselkumab Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.3%
    Check dated 2025-06-20T06:44:43.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.0%
    Check dated 2025-06-13T01:04:30.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-05T21:28:31.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    0.4%
    Check dated 2025-05-29T16:08:58.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page has removed a specific clinical study reference regarding the efficacy and safety of switching to Ixekizumab in psoriasis treatment.
    Difference
    0.1%
    Check dated 2025-05-08T07:01:22.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T03:50:14.000Z thumbnail image

Stay in the know with updates to UNCOVER-2: Guselkumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the UNCOVER-2: Guselkumab Clinical Trial page.